Established in 2006, VHIO is a leading comprehensive cancer center of excellence where its researchers and physician-scientists adopt a purely translational research model, working together as multidisciplinary teams to both accelerate and advance personalized and targeted therapies against cancer.
Undertaking one of Spain´s most dynamic cancer research programs and recognized as a leading reference in drug discovery from concept to the clinic (phase I-II clinical trials), VHIO is dedicated to delivering on the promise of ´precision´medicine in oncology – turning cancer discovery into more effective treatments and better practice for the care of patients.
ICREA is a foundation supported by the Catalan Government established to strengthen the research system in Catalunya, recruiting and retaining top researchers in the Catalan R&D system. They have an excellent track record in technology transfer and lab-to-market initiatives in general.
HealthEquity is a Spanish venture capital firm investing in early-stage companies in the healthcare sector, with a special focus on biotechnology and medical devices. Founded by the Barcelona Medical Association and the financial group Riva y Garcia, HealthEquity is looking for projects to bring successful innovative life science companies to the marketplace and to foster the Catalan and Spanish biotech ecosystem.
Alta Life Sciences is a new leading venture capital investment firm headquartered in Barcelona, that acts as investment advisor to the fund ALSS I FCR. The fund invests in companies at all stages of development: from seed financing through commercial growth, and in all areas of life sciences including biotechnology, medical devices, diagnostics, genomics and digital health.
AurorA Science is a biotech investment company integrating an innovative financial and industrial approach in the research and development challenge. The company is focused on independent and entrepreneurial biotech start-ups in Europe with high therapeutic potential, providing industrial and financial support.
This company is capitalized by Innvierte, an investment program of CDTI, E.P.E.
